论文部分内容阅读
宫颈癌(cancer of cervix)是全球妇女中最常见的恶性肿瘤之一,其发病率仅次于乳腺癌,在世界范围内居女性恶性肿瘤第2位,在发展中国家和地区则居第1位。据世界卫生组织(WHO)报道,全世界每年大约有50万宫颈癌新发病例,其中80%的病例发生在发展中国家。我国每年新发病例14万,约占世界宫颈癌新发病例的28.8%,为我国妇女生殖道恶性肿瘤第1位。近50年来,国内外广泛开展了巴氏涂片和宫颈癌普查、普治工作,使宫颈癌发病率及病死率均有明显下降,但
Cancer of cervix is one of the most common malignant tumors in women worldwide, its incidence rate is second only to that of breast cancer. It ranks the second in the world for female malignancies, and ranks the first in developing countries and regions Bit. According to the World Health Organization (WHO), there are about 500,000 new cases of cervical cancer each year in the world, 80% of which occur in developing countries. China’s annual new cases 140,000, accounting for about 28.8% of new cases of cervical cancer in the world, as China’s female genital tract cancer No. 1. In the recent 50 years, Pap smear and cervical cancer screening and general practice have been carried out extensively at home and abroad, which have significantly reduced the incidence and mortality of cervical cancer